Protease Inhibitors Suppress Fibrinolytic Activity of Herpesvirus-transformed Cells

References

1. Adelman S. F., Howett M. K., Rapp F. 1980; Quantification of plasminogen activator associated with herpesvirus-transformed cells. Journal of General Virology 50:101–110
   [Google Scholar]
2. Adelman S. F., Howett M. K., Rapp F. 1981; Tumorigenicity of herpesvirus-transformed cells correlates with production of plasminogen activator. Molecular and Cellular Biology 1:408–417
   [Google Scholar]
3. Aoyagi T., Umezawa H. 1975; Structures and activities of protease inhibitors of microbial origin. In Proteases and Biological Control vol 2: pp 429–451 Edited by Reich E., Rifkin D., Shaw E. New York: Cold Spring Harbor Laboratory;
   [Google Scholar]
4. Barrett A. J., Starkey P. M. 1974; The unique nature of the interaction of a₂-macroglobulin with proteinases. In Proteinase Inhibitors pp 14–22 Edited by Fritz H., Tschesche H., Green L. J., Truscheit E. Berlin: Springer-Verlag;
   [Google Scholar]
5. Baugh R. J., Schnebli H. P. 1980; Role and potential therapeutic value of proteinase inhibitors in tissue destruction. In Proteinases and Tumor Invasion vol 6: pp 157–180 Edited by Strauli P., Barrett A. J., Baici A. Monograph Series of the European Organization for Research on Treatment of Cancer New York: Raven Press;
   [Google Scholar]
6. Collen D. 1980; Inhibitors of fibrinolysis. In Fibrinolysis pp 130–144 Edited by Kline D. L., Reddy K. N. N. New York: CRC Press;
   [Google Scholar]
7. Collen D., Billiau A., Edy J., Desomer P. 1977; Identification of the human plasma proteins which inhibit fibrinolysis associated with malignant cells. Biochimica et Biophysica Acta 499:194–201
   [Google Scholar]
8. Duff R., Rapp F. 1971; Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. Nature New Biology 233:48–50
   [Google Scholar]
9. Frommer W., Junge B., Muller L., Schmidt D., Truscheit E. 1979; New enzyme inhibitors from microorganisms. Planta Medico 35:195–217
   [Google Scholar]
10. Goetz I. E., Weinstein C., Roberts E. 1972; Effects of protease inhibitors on growth of hamster tumor cells in culture. Cancer Research 32:2469–2474
    [Google Scholar]
11. Harpel P. C. 1976; Human a₂-macroglobulin. Methods in Enzymology 45:639–645
    [Google Scholar]
12. Harpel P. C., Mosesson M. W., Cooper N. R. 1975; Studies on the structure and function of a₂-macroglobulin and Cl inactivator. In Proteases and Biological Control vol 2: pp 387–404 Edited by Reich E., Rifkin D., Shaw E. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
13. Harvey H. A., Lipton A., Albright C., Katz M., Troll W., Rapp F. 1977; Lack of inhibition of metastases by proteolytic inhibitors in an experimental herpesvirus system. Proceedings of the American Association for Cancer Research 18:68
    [Google Scholar]
14. Heimburger N. 1975; Proteinase inhibitors of human plasma – their properties and control functions. In Proteases and Biological Control vol 2: pp 367–386 Edited by Reich E., Rifkin D., Shaw E. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
15. Howett M. K., High C. S., Rapp F. 1978; Production of plasminogen activator by cells transformed by herpesviruses. Cancer Research 38:1075–1078
    [Google Scholar]
16. Hozumi M., Igawa M., Sugemura T., Takeuchi T., Umezawa H. 1972; Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from Actinomycetes. Cancer Research 32:1725–1728
    [Google Scholar]
17. Jeppsson J. O., Laurell C. B. 1975; Function and chemical composition of a, antitrypsin. In Proteases and Biological Control vol 2: pp 405–414 Edited by Reich E., Rifkin D., Shaw E. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
18. Jordan H. 1976; The α-macroglobulins of rat serum. Journal of Biochemistry 159:643–650
    [Google Scholar]
19. Kakizoe T., Esumi H., Kawachi T., Sugemura T., Takeuchi T., Umezawa H. 1977; Further studies on the effect of leupeptin, a protease inhibitor, on induction of bladder tumors in rats by N-butyl-N– (4-hydroxybutyl) nitrosamine. Journal of the National Cancer Institute 59:1503–1508
    [Google Scholar]
20. Kline D. L., Reddy K. N. N. (editors) 1980 Fibrinolysis New York: CRC Press;
    [Google Scholar]
21. Kress L. F., Laskowski M. sr 1974; Purification, properties and composition of α₁-trypsin inhibitor from human plasma. In Proteinase Inhibitors pp 23–30 Edited by Fritz H., Tschesche H., Greene L. J., Truscheit E. Berlin: Springer-Verlag;
    [Google Scholar]
22. Lage A., Diaz J. W., Gonzalez I. 1978; Effect of proteinase inhibitors in experimental tumors. Neoplasma 25:257–259
    [Google Scholar]
23. Ossowski L., Quigley J. P., Reich E. 1975; Plasminogen, a necessary factor for cell migration in vitro. In Proteases and Biological Control vol 2: pp 901–913 Edited by Reich E., Rifkin D., Shaw E. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
24. Reich E., Rifkin D., Shaw E. (editors) 1975 Proteases and Biological Control vol 2: New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
25. Saito M., Hagiwara T., Aoyagi T., Nagai Y. 1972; Leupeptin, a protease inhibitor, inhibits the PHA-stimulated DNA synthesis in guinea pig blood lymphocytes. Japanese Journal of Experimental Medicine 42:509–511
    [Google Scholar]
26. Saito M., Yoshizawa T., Aoyagi T., Nagai Y. 1973; Involvement of proteolytic activity in early events in lymphocyte transformation by phytohemagglutinin. Biochemical and Biophvsical Research Communications 52:569–575
    [Google Scholar]
27. Starkey P. M., Barrett A. J. 1977; α₂-Macroglobulin, a physiological regulator of proteinase activity. In Proteinoses in Mammalian Cells and Tissues pp 663–696 Edited by Barrett A. J. Amsterdam: Elsevier/North-Holland;
    [Google Scholar]
28. Sträuli P., Barrett A. J., Baici A. (editors) 1980 Proteinoses and Tumor Invasion vol 6: Monograph Series of the European Organization for Research on Treatment of Cancer New York: Raven Press;
    [Google Scholar]
29. Travis J., Johnson D., Pannell R. 1974; Properties of human α₁antitrypsin. In Proteinase Inhibitors pp 31–39 Edited by Fritz H., Tschesche H., Greene L. J., Truscheit E. Berlin: Springer-Verlag;
    [Google Scholar]
30. Troll W., Klassen A., Janoff A. 1970; Tumorigenesis in mouse skin: inhibition by synthetic inhibitors of proteases. Science 169:1211–1213
    [Google Scholar]
31. Troll W., Meyn M. S., Rossmann T. G. 1978; Mechanisms of protease action in carcinogenesis. In Carcinogenesis vol 2: pp 301–312 Edited by Slaga T. J., Sivak A., Boutwell R. K. New York: Raven Press;
    [Google Scholar]
32. Umezawa H. 1976; Structures and activities of protease inhibitors of microbial origin. Methods in Enzymology 45:678–695
    [Google Scholar]
33. Umezawa H. 1977; Protease inhibitors produced by microorganisms. Acta Biologica et Medico Germanica 36:1899–1915
    [Google Scholar]
34. Umezawa H. 1978; Metabolites under preclinical development for cancer treatment. Recent Results in Cancer Research 63:120–134
    [Google Scholar]
35. Umezawa H., Aoyagi F. 1977; Activities of proteinase inhibitors of microbial origin. In Proteinases in Mammalian Cells and Tissues pp 637–662 Edited by Barrett A. J. Amsterdam: Elsevier/North-Holland;
    [Google Scholar]
36. Unkeless J. C., Tobia A., Ossowski L., Quigley J. P., Rifkin D. B., Reich E. 1973; An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. Journal of Experimental Medicine 137:85–111
    [Google Scholar]
37. Wingender W. 1974; Proteinase inhibitors of microbial origin – a review. In Proteinase Inhibitors pp 548–559 Edited by Fritz H., Tschesche H., Greene L. J., Truscheit E. Berlin: Springer-Verlag;
    [Google Scholar]
38. Yamanishi K., Rapp F. 1979; Production of plasminogen activator by human and hamster cells infected with human cytomegalovirus. Journal of Virology 31:415–419
    [Google Scholar]